Head and neck cancer survivors patients and late effects related to oncologic treatment: update of literature

被引：0

作者：

Taibi, R. ^{[1
,2
]}

Lleshi, A. ^{[1
]}

Barzan, L. ^{[3
]}

Fiorica, F. ^{[4
]}

Leghissa, M. ^{[2
]}

Vaccher, E. ^{[1
]}

De Paoli, P. ^{[5
]}

Franchin, G. ^{[6
]}

Berretta, M. ^{[1
,7
]}

Tirelli, U. ^{[1
]}

机构：

[1] CRO Aviano Natl Canc Inst, Dept Med Oncol, Aviano, Italy

[2] Pordenone Gen Hosp, Dept Specialized Surg, ORL Unit, Pordenone, Italy

[3] CRO Aviano Natl Canc Inst, Dept Surg, Aviano, Italy

[4] Univ Hosp Ferrara, Dept Radiat Oncol, Ferrara, Italy

[5] CRO Aviano Natl Canc Inst, Sci Directorate, Aviano, Italy

[6] CRO Aviano Natl Canc Inst, Dept Radiat Oncol, Aviano, Italy

[7] IEMEST Palermo, Palermo, Italy

来源：

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2014年 / 18卷 / 10期

关键词：

Cancer; Survivors; Chemotherapy; Radiation therapy; Head and neck cancer survivors; SQUAMOUS-CELL CARCINOMA; MODULATED RADIATION-THERAPY; LOCALLY RECURRENT HEAD; HELICAL TOMOTHERAPY; STEREOTACTIC RADIOTHERAPY; OROPHARYNGEAL CARCINOMA; SWALLOWING DYSFUNCTION; RANDOMIZED-TRIAL; ORAL-CANCER; CHEMOTHERAPY;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Cancer survivorship represents a new challenge in the third Millennium. In Europe the number of cancer survivors was estimated to be 17,8 million in 2008 and this number is growing. Recent improvements in cancer survival are largely due to earlier diagnosis and advancements in treatment. Despite having favorable effects on cancer survival, radiation therapy, surgery treatment and combination chemotherapy regimens can also cause long-term organ damage and functional disabilities. In this paper we review the most important aspects of long-term toxicities in otolaryngology cancer survivors patients.

引用

页码：1473 / 1481

页数：9

共 83 条

[1] Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: Mature results from a single institution [J].

Adelstein, DJ ;

Saxton, JP ;

Rybicki, LA ;

Esclamado, RM ;

Wood, BG ;

Strome, M ;

Lavertu, P ;

Lorenz, RR ;

Carroll, MA .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1064-1071

[2] Optimization of the temporal pattern of radiation: An IMRT based study [J].

Altman, Michael B. ;

Chmura, Steven J. ;

Deasy, Joseph O. ;

Roeske, John C. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03) :898-905

[3] A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC). [J].

Ang, K. K. ;

Zhang, Q. E. ;

Rosenthal, D. I. ;

Nguyen-Tan, P. ;

Sherman, E. J. ;

Weber, R. S. ;

Galvin, J. M. ;

Schwartz, D. L. ;

El-Naggar, A. K. ;

Gillison, M. L. ;

Jordan, R. ;

List, M. A. ;

Konski, A. A. ;

Thorstad, W. L. ;

Trotti, A. ;

Beitler, J. J. ;

Garden, A. S. ;

Spanos, W. J. ;

Yom, S. S. ;

Axelrod, R. S. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[4]

[Anonymous], 1993, Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation

[5]

[Anonymous], ARCH OTOLARYNGOL HEA

[6]

[Anonymous], 2006, SEER CANC STAT REV 1

[7]

[Anonymous], 2008, J NATL COMPR CANC NE

[8]

[Anonymous], MUC GUID

[9] GENOMIC INSTABILITY IN CANCER Strategies to improve radiotherapy with targeted drugs [J].

Begg, Adrian C. ;

Stewart, Fiona A. ;

Vens, Conchita .

NATURE REVIEWS CANCER, 2011, 11 (04) :239-253

[10]

Bensinger William, 2008, J Natl Compr Canc Netw, V6 Suppl 1, pS1

← 1 2 3 4 5 6 7 8 9 →